EFFICACY AND TOLERABILITY OF CONCOR IN PATIENTS WITH NEWLY DIAGNOSED STAGE-I ESSENTIAL HYPERTENSION.
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Bisoprolol (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Merck Serono
- 03 Jun 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 24 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 18 Jun 2010 New trial record